Weed BUDZ
OTC BUDZ
$0.03 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT

Weed (BUDZ) Notes Payables (2010 - 2025)

Weed (BUDZ) posted quarterly Notes Payables of $348018.0 for Q3 2025, up 9406.09% year-over-year from $3661.0 in Q3 2024, and up 0.74% quarter-over-quarter from $345455.0 in Q2 2025.

Weed (BUDZ) Notes Payables (2010 - 2025) Analysis & Trends

Weed's Notes Payables history runs 12 years deep, the most recent figure standing at $348018.0 for Q3 2025.

  • In Q3 2025, Notes Payables rose 9406.09% year-over-year to $348018.0; the TTM figure through Sep 2025 stood at $348018.0 (up 9406.09% YoY), while the FY2024 annual figure was $423328.0, up 11463.18% from the prior year.
  • Notes Payables for Q3 2025 stood at $348018.0, up from $345455.0 in the prior quarter.
  • The five-year high for Notes Payables was $897661.0 in Q2 2022, with the low at $3661.0 in Q4 2022.
  • The 5-year median for Notes Payables is $75822.0 (2021), against an average of $246495.9.
  • The sharpest annual moves came in 2023 and 2024: Notes Payables sank 99.59% in 2023, then surged 11463.18% in 2024.
  • Weed's Notes Payables stood at $65607.0 in 2021, then sank by 94.42% to $3661.0 in 2022, then changed by 0.0% to $3661.0 in 2023, then soared by 11463.18% to $423328.0 in 2024, then retreated by 17.79% to $348018.0 in 2025.
  • Business Quant data shows BUDZ's Notes Payables at $348018.0 in Q3 2025, $345455.0 in Q2 2025, and $340891.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Weed 3.13 Mn 3.13 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 348,018.00
Jun 30, 2025 345,455.00
Mar 31, 2025 340,891.00
Dec 31, 2024 423,328.00
Sep 30, 2024 3,661.00
Jun 30, 2024 3,661.00
Mar 31, 2024 3,661.00
Dec 31, 2023 3,661.00
Sep 30, 2023 3,661.00
Jun 30, 2023 3,661.00
Mar 31, 2023 3,661.00
Dec 31, 2022 3,661.00
Sep 30, 2022 763,454.00
Jun 30, 2022 897,661.00
Mar 31, 2022 802,999.00
Dec 31, 2021 65,607.00
Sep 30, 2021 303,700.00
Jun 30, 2021 75,822.00
Mar 31, 2021 287,200.00
Dec 31, 2020 258,200.00